Insmed to Present Abstracts on NTM Lung Infection Therapy For Bronchiectasis, Cavitary Disease
News
Biopharmaceutical Insmed Incorporated will present data on its therapy for nontuberculous mycobacterial (NTM) lung infections, called ARIKAYCE, at the upcoming American Thoracic Society (ATS) 2015 International Conference, which will take place between May 15th and ... Read more